Scientific publications

Lack of Bcr-Abl point mutations in chronic myeloid leukemia patients in chronic phase before imatinib treatment is not predictive of response

Dec 1, 2003 | Magazine: Haematologica

Agirre X, Fontalba A, Andreu EJ, Odero MD, Larráyoz MJ, Montiel C, Calasanz MJ, Fernández-Luna JL, Prósper F

No abstract available

CITA DEL ARTÍCULO  Haematologica. 2003 Dec;88(12):1425-6

see publication in pubmed

Our authors

Imagen Dr. Felipe Prósper Cardoso, Área de Terapia Celular.
Dr. Felipe Prósper Cardoso Curriculum
Director The Advanced Therapies Unit
Navarre headquarters
Madrid headquarters